We are developing the first digital therapeutic for Perinatal Mood & Anxiety Disorders using extended reality (XR) and AI. The goal is to improve care outcomes and effectiveness of treatment for pregnant and postpartum mothers, including opioid addicted mothers suffering from anxiety/depression as a dual co-morbidity, a key cause of overdose.